1 Dupilumab is a fully human monoclonal antibody (mAb) that inhibits the signaling of IL-4 and IL-13 pathways and does not act as an immunosuppressant. 2 The approval was based on the results from ...

Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron ...